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doi:10.1016/j.jfma.2011.08.007Background: The von Hippel-Lindau (VHL) tumor suppressor gene located on chromosome
3p25-26 is implicated in VHL disease. Two informative single nucleotide polymorphisms are
at positions 19 and 1149 on the nucleotide sequence from Gene Bank NM_000551. In this study
we examined the allele frequencies at these two loci in the Taiwanese population and
compared the results to those from European ethnic populations.
Methods: The allele frequency was examined in 616 healthy individuals including 301 univer-
sity students and 315 neonates. Both A/G polymorphisms were investigated using restriction
fragment length polymorphism analysis created by restriction enzymes, BsaJ I and Acc I.
Results: Among these subjects, the allele frequencies at 19 SNP and 1149 SNP for variant G
were 0.130 and 0.133, respectively. And these results were significant differences from those
of the Caucasian populations. In addition, 90% of the tested subjects had identical genotypes
at these two loci suggesting the existence of nonrandom association of alleles.
Conclusion: We found that the G allele frequency at these two loci in the Taiwanese popula-
tion is much lower than that in people from Western countries. This phenomenon may be
attributed to ethnic effects.
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frequencies of 19 and 1149 SNPs in the VHL tumorA variety of important neoplasms has been reported to
be associated with von Hippel-Lindau (VHL) disease (OMIM
193300), an autosomal dominant tumor syndrome, including
clear cell renal tumors, pheochromocytomas, retinal angi-
omas and cerebellar and spinal hemangioblastomas.1 Many
studies have been conducted to unveil the causes of this
syndrome. For example, the VHL tumor suppressor gene
was mapped to chromosome 3 in 1988 and the VHL gene was
identified in 1993.2,3 The VHL gene is located on chromo-
some 3p25-3p26 and consists of 3 exons that encode 213
amino acids.4 The promoter region was mapped and the
major transcription initiation site was identified in 1995.5 In
1996, the 3’ untranslated region (3’UTR) was isolated.6
Genetically, VHL disease is caused by the inactivation of
the VHL tumor suppressor gene.7e9 VHL gene function is
disrupted in sporadic renal cell carcinoma (RCC) as well as
in hereditary VHL syndrome through mutation.9 The
product of VHL gene (pVHL) is a multifunctional tumor
suppressor.10 The pVHL is a component of E3 ubiquitin
ligase complex which regulating the HIF-a (hypoxia-
inducible factor alpha).11 Loss of pVHL function will prevent
HIF- a degradation.12 The increased level of HIF-a will then
promote tumorigenesis such as clear cell RCC.12 In addition
to deletion and point mutations, DNA hypermethylation has
been observed as a third mechanism to inactivate the VHL
gene.13,14 However, the molecular mechanisms controlling
gene specific local de novo and maintenance methylation
are still poorly understood.15
Differences in human DNA often account for the risk of
certain diseases and sensitivity to drug therapy even when
these differences are minor.16 There are two informative
single nucleotide polymorphisms (SNP) in the VHL gene
noted to loss of heterozygosity in patients with sporadic
RCC.17,18 Both are biallelic polymorphisms with either an A
or a G at positions 19 and 1149 on the nucleotide sequence
according to GenBank accession number NM_000551.19,20
The location of 19 SNP is 128 bp upstream from the major
transcription starting site within the promoter region of
the VHL gene and the location of 1149 SNP is in the 3’
untranslated region (3’UTR). To date, molecular genetic
studies are mainly from Western countries, and Asian
studies are mostly from Japan. Since ethnic and geographic
differences may be strongly associated with dramatically
different polymorphism patterns, the establishment of
a polymorphism database specific to different countries is
essential. In addition, white, black and Hispanic pop-
ulations have more than double the age-adjusted incidence
rates for RCC compared to Asian/Pacific Islanders.21 In
Taiwan population, acquired cystic disease-associated RCC
has been reported to have frequent abnormalities on
chromosome 3.22 However no studies have focused on VHL
gene in Taiwan yet. Therefore, the investigation of the
polymorphisms in the VHL tumor suppressor gene in the
Taiwanese population would be beneficial to the under-
standing of the etiology of VHL disease and to the search for
potential therapeutic targets for treating different
neoplasms resulting from VHL gene expressional/functional
alterations. Therefore, in the current study we collectedcertain genomic information by examining the allele
suppressor gene in over 600 healthy individuals from the
Taiwanese population using restriction fragment length
polymorphisms (RFLP) of BsaJ I and Acc I. The results were
compared to those of European ethnicities.Materials and methods
Study subjects
Due to the rather small sample sizes in the groups we used
to compare, more than six hundred samples were collected
in the current study in order to reach the statistic power.
616 apparently healthy subjects including 301 college
students and 315 neonates were included in the current
study. The student peripheral blood samples were collected
from Chung Shan Medical University and the student census
registers were distributed all over Taiwan. The fetal
umbilical cord blood samples were collected from the
Department of Obstetrics and Gynecology of Jen-Ai
Hospital and the mothers’ residencies were distributed
throughout the central region of Taiwan. The Institutional
Review Board of Jen-Ai Hospital approved all the proce-
dures including the DNA sample collection for VHL SNP
study, and patient or parental informed consent was ob-
tained prior to collecting genetic material for the study.
Preparation of genomic DNA
The buffy coat was prepared by centrifuging whole blood at
3300 g for 10 min at room temperature. After centrifuga-
tion, the intermediated layer that is buffy coat, containing
concentrated leukocytes was isolated. Genomic DNA was
extracted from buffy coat leukocytes using the QIAamp DNA
blood mini kit according to the manufacturer’s recom-
mendations (Qiagen Scientific Instruments).
Polymerase Chain Reaction (PCR)
The DNA fragments that contained 19 and 1149 SNPs were
amplified according to the protocols published by other
groups.19,20 A slight modification was made in PCR primers
for 19 and 1149 SNPs as follows: 19 SNP-F, 50-AGCCTCGCCTC
CGTTACCAC-30; 19 SNP-R, 50-GTAGAGGATGGAACGCGCT-30;
1149 SNP-F, 50-CTGCCCATTAGAGAAGTATTT-30; 1149 SNP-R,
50-AATTCCCACTGAATTACGTATA-30. The PCR fragments
were amplified in a Perkin-Elmer 2400 DNA thermal cycler
in a final volume of 15 to 30 ml that contained one-fold
Qiagen PCR buffer [Tris-HCl, KCl, (NH4)2SO4, 15 mM MgCl2;
pH 8.7 at 20 C], one-fold Q-solution, 0.015 units/ml Taq
DNA polymerase supplied from Taq DNA polymerase kit
(Qiagen), 500 nM for each primer, 200 mM dGTP, dATP, dCTP
and dTTP (Promega) and 300 ng/ml template. The PCR
conditions were initial denatured at 95 C for 5 min, fol-
lowed by 35 cycles of 1 min at 95 C, 1 min at 60 C for 19
SNP or 50 C for 1149 SNP, and 2 min at 72 C, with final
extension at 72 C for 10 min.
Figure 1 Examples of 19 and 1149 SNPs identified in Taiwanese subjects. (A) RFLP analysis was used to screen for the allele
genotype of 19 SNP by BsaJ I digestion methods. Lanes 1 and 4-6 are homozygous with A allele that the 101-bp PCR fragments were
uncleaved. Lanes 3 and 7 are homozygous with G allele that the 101-bp PCR fragments were cleaved into the fragments of 83-bp
and 18-bp in length. The 18-bp fragments were run off the gel. Lane 2 is heterozygous with A allele and G allele. M is molecular
weight markers of 100-bp and 200-bp. (B) RFLP analysis was used to screen for the allele genotype of 1149 SNP by Acc I digestion
methods. Lanes 1-6 are homozygous with A allele that the 110-bp PCR fragments were uncleaved. Lanes 7 is heterozygous with A
allele and G allele that the 101-bp PCR fragments were cleaved into the fragments of 88-bp and 22-bp in length. The 22-bp
fragments were run off the gel. M is molecular weight markers of 50-bp, 100-bp, and 200-bp on the same gel.
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An aliquot of 10 ml of PCR product was digested with 2.5
units BsaJ I (New England Biolabs) for 19 SNP or 2.5 units
Acc I (New England Biolabs) for 1149 SNP in a total volume
of 20 ml that contained one-fold NEBuffer 2 or NEBuffer 4.
The samples were digested at 60 C for 19 SNP or 37 C for
1149 SNP for 4 hrs followed by heat inactivation of the
restriction enzyme at 80 C for 20 min. After digestion, the
products were separated onto 3% agarose gels. To avoid
genotyping errors, we repeated the analysis at least twice
for every sample. Also, proportion of the PCR products was
sent for direct sequencing, and the data were consistent
with the genotyping.
Statistical analysis
Standard normal deviate (z) test or chi-square test was
used to compare the allele frequencies between Taiwanese
and Europeans. Two-tailed p values of less than 0.05 were
considered statistically significant. In addition, the chi-
square goodness-of-fit test was performed to examine if
local population deviated from Hardy-Weinberg Propor-
tions. The observed genotype frequencies were compared
with expected numbers calculated from Hardy-Weinberg
equilibrium theory (p2 þ 2pq þ q2 Z 1, where p is the
frequency of the wild-type allele and q is the frequency ofTable 1 Genotype and allele frequency at 19 SNP in the prom
population
Population Number of samples Genot
AA
CEPH 73 0.438 (32)
Taiwanese
Neonates* 315 0.771 (243)
Students* 301 0.754 (227)
Total* 616 0.763 (470)
*p < 0.05 compared with the CEPH (Centre d’Etude du Polymorphismthe variant allele). In addition, we calculated the pair-wise
linkage disequilibrium parameter D by using the formula
that D Z PA1A2  PG1G2  PA1G2  PG1A2 from Table 4.23
Results
Allele frequency of 19 SNP
RFLP analysis was used to screen for the allele genotype of
19 SNP, located 128 bp upstream from the major tran-
scription starting site within the promoter region of the VHL
tumor suppressor gene, by BsaJ I digested.19 The repre-
sentative gel is shown in Fig. 1. For the pooled 616 appar-
ently healthy subjects, the observed allele frequencies for
A and G were 0.870 and 0.130, respectively, and the
observed heterozygosity was 0.214. There are statistically
significant differences between Taiwanese and European
populations (Z Z 5.56, p Z 2.71  108; Table 1)19 sug-
gesting a significant difference in 19 SNP promoter of VHL
gene between these two populations.
The sampled healthy Taiwanese population was further
divided into two sub-populations, 301 unrelated university
students and 315 neonates from a local hospital repre-
senting geographically overall and regional Taiwanese
populations, respectively. These two groups also represent
the age populations of those in the twenties and newborns,
respectively. The observed allele frequency of universityoter region of VHL tumor suppressor gene in the Taiwanese
ype frequency (counts) Allele frequency
AG GG A G
0.356 (26) 0.206 (15) 0.62 0.38
0.203 (64) 0.025 (8) 0.873 0.127
0.226 (68) 0.020 (6) 0.867 0.133
0.214 (132) 0.023 (14) 0.870 0.130
e Humain).
19
Table 3 Goodness-of Fit to the Hardy-Weinberg Propor-
tions of 315 Neonates for 1149 SNP (p Z 0.886 and
q Z 0.114)
Genotype AA AG GG Total
Observed
Numbers (O)
252 54 9 315
Expected
Proportions
p2 (0.785) 2pq (0.202) q2 (0.013) 1
Expected
Numbers (E )
247.27 63.63 4.10 315.0
c2 Z (Oe E )2/E 0.090 1.457 5.856 7.403y
yThe observed genotype frequency in the Taiwanese population
was not in agreement with the Hardy-Weinberg equilibrium
(p2 þ 2pq þ q2 Z 1) (c2 Z 7.403, p < 0.05).
Two SNPs in the VHL gene in Taiwanese 649students for A was 0.867 and for variant G was 0.133.
Observed heterozygosity was 0.226. The observed allele
frequency of neonates for A was 0.873 and for variant G
was 0.127. Observed heterozygosity was 0.203. There is no
significant difference between university students and
neonates (Z Z 0.22, p Z 0.825; Table 1). However, the
allele frequencies of the two Taiwanese sub-populations are
significantly different from those of Europeans (Z Z 5.13
and 4.92, p Z 2.89  107 and 8.88  107; Table 1).
Next, we examined the goodness-of-fit within the Hardy-
Weinberg equilibrium of the Taiwanese population. The
university student and neonate populations were pooled
due to the lack of differences between these two groups.
We calculated whether the frequencies of the three geno-
types (AA, AG and GG or A1A1, A1A2 and A2A2) agreed with
the frequencies of p2, 2pq, and q2 (Table 2)20. The critical
chi-square for one degree of freedom at p Z 0.05 was
3.841. The overall Taiwanese population did not deviate
from Hardy-Weinberg Proportions at 19 SNP (c2 Z 1.655,
p Z 0.437). The genotype distributions for both student
and newborn subgroups also agreed with the Hardy-
Weinberg equilibrium (c2 Z 0.117 and 2.203, p Z 0.943
and 0.332). These results suggest that the healthy Taiwa-
nese population is within the Hardy-Weinberg equilibrium
at 19 SNP.
Allele frequency of 1149 SNP
RFLP analysis was used to screen for the allele genotype of
1149 SNP, in the 3’UTR of VHL gene, by Acc I digested.20 The
results and relevant data are summarized in Table 2. For
the pooled healthy Taiwanese population, the observed
allele frequency of A was 0.867 and of variant G was 0.133.
The observed heterozygosity was 0.218. The observed
allele frequencies of the university students for A and G
were 0.847 and 0.153, respectively, and the observed
heterozygosity was 0.266. The observed allele frequencies
of the newborn babies for A and G were 0.886 and 0.114
respectively, and the observed heterozygosity was 0.171.
There was no difference in the allele frequencies between
these two Taiwanese sub-groups (Z Z 1.43, p Z 0.154).
However, the difference in the allele frequencies between
pooled Taiwanese and European populations was statisti-
cally significant (Z Z 3.93, p Z 8.51  105). Also, the
allele frequencies of the sub-populations of Taiwanese
were different from those of Europeans (ZZ 3.11 and 4.18Table 2 Genotype and allele frequency at 1149 SNP in the 3
Taiwanese population
Population Number of samples Gen
AA
British Caucasian 62 0.468 (29)
Taiwanese
Neonates* 315 0.800 (252)
Students* 301 0.714 (215)
Total* 616 0.758 (467)
*p < 0.05 compared with British Caucasians.
20for students and neonates respectively, p Z 1.89  103
and 2.96  105).
Our results indicated that the pooled Taiwanese pop-
ulation did not deviate from Hardy-Weinberg Proportions
at the 1149 SNP (c2 Z 2.033, p Z 0.362). However, the
genotype distribution of the sub-group of newborn babies
deviated from the Hardy-Weinberg Proportions (c2Z 7.403,
p Z 0.0247; Table 3), while that of the university student
population did not (c2 Z 0.210, p Z 0.900).
Interallelic disequilibrium
About 90% of the tested subjects, or 554 of 616 subjects,
had identical genotypes at these two loci, which means
that when a gamete contains A allele in 19 SNP it is most
likely to also contain A allele in 1149 SNP rather than
a randomly chosen gamete. Likewise, a gamete containing
G allele in 19 SNP is most likely to also contain G allele in
1149 SNP. Only 10% of the subjects, 62 out of 616, showed
different genotypes at these two loci. The underlying
causes behind this phenomenon may be (1) high allele
frequencies of A at these two loci among the present
subjects or (2) nonrandom association of alleles at different
loci (gametic disequilibrium). In order to determine the
possible gametic correlation between these two loci, we
further examined the linkage disequilibrium of these two
loci by calculating the normalized linkage disequilibrium
coefficient (D) (Table 4).24 The observed disequilibrium
coefficients for the university students and the newborn’ untranslated region of VHL tumor suppressor gene in the
otype frequency (counts) Allele frequency
AG GG A G
0.435 (27) 0.097 (6) 0.68 0.32
0.171 (54) 0.029 (9) 0.886 0.114
0.266 (80) 0.020 (6) 0.847 0.153
0.218 (134) 0.024 (15) 0.867 0.133
Table 4 Gametic disequilibrium of 19 SNP and 1149 SNP in
the Taiwanese population
Gemete frequencies Allele frequencies
Population A1A2 A1G2 G1A2 G1G2 P1 P2 D
Neonates 0.818 0.068 0.056 0.059 0.873 0.886 0.044
Students 0.783 0.064 0.084 0.069 0.867 0.847 0.049
Total 0.801 0.066 0.069 0.064 0.870 0.867 0.046
1 represents 19 SNP; 2 represents 1149 SNP.
650 W.-C. Wang et al.babies were 0.049 and 0.044, respectively, and the pooled
disequilibrium coefficient was 0.046. As the linkage
disequilibrium coefficient (D) was not zero, nonrandom
association of alleles between these two loci is supported.
Discussion
The results of the current study indicate a genetic demar-
cation between Caucasian and Taiwanese populations. We
found that A allele frequencies at both SNPs from healthy
Taiwanese samples were much higher (in Table 1, 0.87 vs
0.62; in Table 2, 0.87 vs 0.68) and G allele frequencies were
much lower than those reported from Western countries (in
Table 1, 0.13 vs 0.38; in Table 2, 0.13 vs 0.32), indicating
a strong association with ethnicity.
The VHL gene dysfunction is observed in sporadic RCC as
well as in hereditary cases.13,25,26 Patients with sporadic
RCC have been shown to lose the heterozygosity of two
SNPs in VHL gene,17,18 presenting with a biallelic poly-
morphism with either an A or a G at positions 19 and 1149 in
the nucleotide sequence.19,20 It has been reported that the
age-adjusted incidence rates for RCC are higher in black
men and women than in white men and women, 11.1 vs 9.6
for men and 4.9 vs 4.4 for women per 100 thousand people
per year.27 A similar tendency, 0.23 for Chinese, 0.25 for
Japanese, 0.38 for European, and 0.88 for Sub-Saharan
African, for G allele frequency at 19 SNP and 1149 SNP is
also noted in the population diversity in the SNP database
of the National Center for Biotechnology Information,
rs779805 and rs1642742 (http://www.ncbi.nlm.nih.gov/
SNP_ref.cgi?rsZ779805 and http://www.ncbi.nlm.nih.
gov/SNP_ref.cgi?rsZ1642742). It seems that the pop-
ulation with a higher G frequency also has a higher preva-
lence of RCC (Supplemental Figure 1). Our results showed
that the G allele frequency is about 0.13 at both SNPs in
the Taiwanese population, which is the lowest G allele
frequency among all of the available data. Consistent with
the association of a lower G allele frequency with a lower
RCC incidence rate, the Taiwanese population had the
lowest RCC incidence rate of all compared ethnic groups
(Supplemental Figure 1; 3.62 for men and 1.95 for women in
2005 per 100 thousand people per year; reported by Taiwan
Cancer Registry of Health Promotion Bureau, Department of
Health, R.O.C. Taiwan). Further, our preliminary data in 19
patients with RCC showed that G allele frequency increased
from control level of 0.130 to 0.184 at the 19 SNP and from
0.133 to 0.210 at the 1149 SNP (Supplemental Table 1, The
Institutional Review Board of Chung Shan Medical University
Hospital approved the DNA sample collection for the VHL
SNP study). Possible protective effects may be gained whenthe G allele is changed into the A allele such as in the
Taiwanese population. Similarly, if the G allele frequency is
increased, the susceptibility to RCC may also increase.
However, further studies are needed to clarify this
hypothesis.
Previous reports have shown that VHL gene malfunction
may be due to gene mutation9 and/or DNA hyper-
methylation to suppress the VHL gene expression.13,14 The
abnormal methylation may be caused and/or maintained by
either deficiency of some trans-acting factor(s) or by
various malfunctions acting in cis. VHL gene methylation
has been reported to be a specific and important indicator
in the pathogenesis of clear cell RCC.13 Possibly, this
genetic polymorphism is a cis-acting factor that is pivotal in
maintaining and perpetuating aberrant methylation of
the VHL CpG islands. However, further investigation is
required. Since minor differences in DNA may predict the
risk of certain diseases, the genetic polymorphism in these
two loci may be a susceptibility factor for VHL gene-related
tumors such as RCC. However this hypothesis also requires
further investigation in clinical human patients with renal
carcinoma.
The allele frequencies in 19 SNP from both sub-groups of
the healthy Taiwanese population agreed with the Hardy-
Weinberg equilibrium. However, the allele frequency for
the sub-group of newborn babies in 1149 SNP deviated from
Hardy Weinberg Proportions (Table 3). The potential
underlying cause may be resulted from several huge
immigration waves over the past 10-15 years, which has
significantly altered the gene pool in Taiwan. In 1998, 5.12%
of newborns and in 2002, 12.46% of newborns were born to
immigrant women (reported by Child Welfare Bureau,
Ministry of the Interior, R.O.C. Taiwan). The admixture of
sub-populations that differ in allele frequencies also causes
changes in disequilibrium coefficient (D) (Table 4), from
0.049 to 0.044 from one generation to the next.
In conclusion, our data showed that the Taiwanese
population has the highest A and lowest G allele frequen-
cies in both SNPs compared to currently available data,
suggesting that an ethnic effect underlies these differ-
ences. Due to the fact that the VHL gene is also an RCC
susceptibility gene,4,13,28 the lowest G allele frequency in
these two SNPs is associated with the lowest RCC incidence
rate for the Taiwanese population. This suggests that G
allele frequency is an important risk-determining factor for
RCC as well as other VHL gene-related neoplasms. Our
current findings in the allele frequency of two SNP in the
VHL tumor suppressor genes in the Taiwanese population
will benefit the understanding of the ethnic effects on VHL
disease as well as its etiology. And the frequency seems to
parallel the incidence of renal cell carcinoma. It may be
help to arrange the distribution of health resources due to
the decreasing tendency of G allele.Acknowledgments
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